Nova New England Limited In Receivership

On March 16, 2010, BDO Canada Limited was appointed as Receiver or Receiver/Manager of the assets of Nova New England Limited ("NNE") pursuant to certain security held by Addenda Capital Inc. Please proceed to the "Documents" page on this website for a copy of the appointment letter.

We hope to communicate further information with regard to our receivership appointment through this website as it becomes available.

Documents

Please click the links below to view the document:

• Order Discharging Receiver - Issued July 21, 2011
• Order Confirming Sale - Issued June 24, 2011
• Order for Default Judgment – Issued February 17, 2011
• Report of Court-Appointed Receiver - February 11, 2011
• Order Transferring Agreements of Sale and Supply Agreements - Issued September 14, 2010
• Notice of Public Auction
• Order for Foreclosure, Sale and Possession - Issued June 22, 2010
• Order for Receiver or Receiver and Manager – Issued April 14, 2010
• Addenda - Draft Order
• Addenda Brief
• Addenda - Notice of Action
• Addenda - Notice of Motion
• Affidavit of Elvira Dube
• Affidavit of Paul Goodman
• Notice of Receiver or Receiver/Manager [S.245(1)]
• Receiver's Appointment Letter

Statements Of Receipts And Disbursements

Please click the links below to view the document:

• R&D as of November 4
• R&D as of October 28
• R&D as of October 21
• R&D as of October 14
• R&D as of October 7
• R&D as of September 30
• R&D as of September 23
• R&D as of September 16
• R&D as of September 9
• R&D as of September 2
• R&D as of August 26
• R&D as of August 19
• R&D as of August 12
• R&D as of August 5
• R&D as of July 29
• R&D as of July 22
• R&D as of July 15
• R&D as of July 8
• R&D as of July 1
• R&D as of June 24
• R&D as of June 17
• R&D as of June 10
• R&D as of June 3
• R&D as of May 27
• R&D as of May 20
• R&D as of May 13
• R&D as of May 6
• R&D as of April 29
• R&D as of April 22
• R&D as of April 15
• R&D as of April 8
• R&D as of April 1
• R&D as of March 25
• R&D as of March 18
• R&D as of March 11
• R&D as of March 4
• R&D as of February 25